eMedicine Specialties > Radiology > Chest

Pneumonia, Atypical Bacterial: Follow-up

Author: Shakeel Amanullah, MD, Consulting Staff, Pulmonary, Critical Care, and Sleep Medicine, Clarian Arnett Health
Coauthor(s): David H Posner, MD, Assistant Professor of Medicine, New York University School of Medicine; Assistant Chief of Pulmonary Diseases, Instructor, Intensive Care Unit, Education Coordinator for Pulmonary Fellowship, Lenox Hill Hospital; Mina Farhad, MD, PhD, Clinical Instructor of Radiology, New York University School of Medicine; Head of Thoracic Imaging, Department of Radiology, Lenox Hill Hospital; Klaus-Dieter Lessnau, MD, FCCP, Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory; Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital
Contributor Information and Disclosures

Updated: Mar 7, 2008

Intervention

Legionella pneumonia

Delay in the treatment of Legionella pneumonia is associated with a significantly increased mortality rate.

The newer macrolides, especially azithromycin, have superior in vitro activity, with more intracellular and lung tissue penetration than erythromycin. Quinolones have even greater in vitro activity and better intracellular penetration than the macrolides.

In severely ill patients, rifampin may be used in combination with the macrolides or quinolones.

The duration of therapy is 10-14 days, with a 21-day regimen for immunosuppressed patients or those with extensive disease, as shown on chest radiographs. Chest radiographic findings may continue to deteriorate despite clinical improvement.

Mycoplasma pneumonia

In most cases, recommended treatment for Mycoplasma pneumonia includes tetracycline or a macrolide. Fluoroquinolones also may be used. Two to three weeks of therapy is generally recommended to lessen the risk of relapse.

Chlamydia pneumonia

Chlamydia pneumonia may be treated with doxycycline, a macrolide, or a fluoroquinolone. The preferred diagnostic result is a 4-fold increase in titers from the acute stage to convalescence, with supporting evidence from PCR or culture tests. Therefore, most laboratories cannot confirm the diagnosis in a timely fashion; the treatment of this pneumonia should be empirical.


 


More on Pneumonia, Atypical Bacterial

Overview: Pneumonia, Atypical Bacterial
Imaging: Pneumonia, Atypical Bacterial
Follow-up: Pneumonia, Atypical Bacterial
Multimedia: Pneumonia, Atypical Bacterial
References

References

  1. Gallagher JR. Bronchopneumonia in adolescence. Yale J Biol Med. 1934;7:23-40.

  2. Gouriet F, Drancourt M, Raoult D. Multiplexed serology in atypical bacterial pneumonia. Ann N Y Acad Sci. Oct 2006;1078:530-40. [Medline].

  3. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. May 15 2007;175(10):1086-93. [Medline].

  4. Masiá M, Gutiérrez F, Padilla S, Soldán B, Mirete C, Shum C, et al. Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clin Microbiol Infect. Feb 2007;13(2):153-61. [Medline].

  5. Garibaldi RA. Epidemiology of community acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med. 1985;78:32S-37S.

  6. Neiderman MS, McCombs JI, Unger AN. The cost of treating community acquired pneumonia. Clin Ther. 1998;20:820-837.

  7. Niederman MS, Mandell LA, Anzueto A. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. Jun 2001;163(7):1730-54. [Medline].

  8. Mansel JK, Rosenow EC, Smith TF. Mycoplasma pneumoniae pneumonia. CHEST. 1989;95:639-646.

  9. Pareja A, Bernal C, Leyva A. Etiologic study of patients with community acquired pneumonia. CHEST. 1992;101:1207-1210.

  10. Sutherland ER, Brandorff JM, Martin RJ. Atypical bacterial pneumonia and asthma risk. J Asthma. 2004;41(8):863-8. [Medline].

  11. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest. Dec 2007;132(6):1962-6. [Medline].

  12. Marrie TJ. Community acquired pneumonia: epidemiology, etiology, treatment. Infect Dis Clin North Am. 1998;12(3):723-740.

  13. Pinar A, Bozdemir N, Kocagöz T, Alaçam R. Rapid detection of bacterial atypical pneumonia agents by multiplex PCR. Cent Eur J Public Health. Mar 2004;12(1):3-5. [Medline].

  14. Tanaka N, Matsumoto T, Kuramitsu T, et al. High resolution CT findings in community-acquired pneumonia. J Comput Assist Tomogr. Jul-Aug 1996;20(4):600-8. [Medline].

  15. Yagyu H, Nakamura H, Tsuchida F, et al. Chest CT findings and clinical features in mild Legionella pneumonia. Intern Med. Jun 2003;42(6):477-82. [Medline].

  16. Reittner P, Muller NL, Heyneman L, et al. Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features in 28 patients. AJR Am J Roentgenol. Jan 2000;174(1):37-41. [Medline].

  17. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. Dec 14 1995;333(24):1618-24. [Medline].

  18. Chanock RM. Mycoplasma pneumoniae: proposed nomenclature for atypical pneumonia organism (Eaton agent). Science. May 10 1963;140:662. [Medline].

  19. Clyde WA. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis. Aug 1993;17 Suppl 1:S32-6. [Medline].

  20. Coletta FS, Fein AM. Radiological manifestations of Legionella/Legionella-like organisms. Semin Respir Infect. Jun 1998;13(2):109-15. [Medline].

  21. Dietrich PA, Johnson RD, Fairbank JT, Walke JS. The chest radiograph in legionnaires'' disease. Radiology. Jun 1978;127(3):577-82. [Medline].

  22. Fairbank JT, Mamourian AC, Dietrich PA, Girod JC. The chest radiograph in Legionnaires'' disease. Further observations. Radiology. Apr 1983;147(1):33-4. [Medline].

  23. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires'' disease: description of an epidemic of pneumonia. N Engl J Med. Dec 1 1977;297(22):1189-97. [Medline].

  24. Heussel CP, Kauczor HU, Heussel G, et al. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol. Nov 1997;169(5):1347-53. [Medline].

  25. Hughes JA, Anderson PB. Pulmonary cavitation, fibrosis and Legionnaires'' disease. Eur J Respir Dis. Jan 1985;66(1):59-61. [Medline].

  26. Kroboth FJ, Yu VL, Reddy SC, et al. Clinicoradiographic correlation with the extent of Legionnaire disease. AJR Am J Roentgenol. Aug 1983;141(2):263-8. [Medline].

  27. Lake KB, Van Dyke JJ, Gerberg E, Browne PM. Legionnaires'' disease and pulmonary cavitation. Arch Intern Med. Apr 1979;139(4):485-6. [Medline].

  28. Macfarlane JT, Miller AC, Roderick Smith WH, et al. Comparative radiographic features of community acquired Legionnaires'' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis. Thorax. Jan 1984;39(1):28-33. [Medline].

  29. Meenhorst PL, Mulder JD. The chest X-ray in Legionella Pneumonia (Legionnaires'' disease). Eur J Radiol. Aug 1983;3(3):180-6. [Medline].

  30. Moore EH, Webb WR, Gamsu G, Golden JA. Legionnaires'' disease in the renal transplant patient: clinical presentation and radiographic progression. Radiology. Dec 1984;153(3):589-93. [Medline].

  31. Muder RR, Yu VL, Parry MF. The radiologic manifestations of Legionella pneumonia. Semin Respir Infect. Dec 1987;2(4):242-54. [Medline].

  32. Reimann HA. Landmark article Dec 24,1938: An acute infection of the respiratory tract with atypical pneumonia. A disease entity probably caused by a filtrable virus. By Hobart A. Reimann. JAMA. Feb 17 1984;251(7):936-44.

Further Reading

Keywords

walking pneumonia, atypical pneumonia, Legionella pneumonia, Chlamydia pneumonia, Mycoplasma pneumonia, Mycobacterium tuberculosis, community-acquired pneumonia, CAP, Legionnaires disease, Legionnaire's disease, Legionnaires' disease, Legionella pneumophila, Legionella micdadei, Mycoplasma hominis, Ureaplasma urealyticum, Chlamydia psittaci, Chlamydia trachomatis, Chlamydia pneumoniae, TWAR agent

Contributor Information and Disclosures

Author

Shakeel Amanullah, MD, Consulting Staff, Pulmonary, Critical Care, and Sleep Medicine, Clarian Arnett Health
Shakeel Amanullah, MD is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

David H Posner, MD, Assistant Professor of Medicine, New York University School of Medicine; Assistant Chief of Pulmonary Diseases, Instructor, Intensive Care Unit, Education Coordinator for Pulmonary Fellowship, Lenox Hill Hospital
Disclosure: Nothing to disclose.

Mina Farhad, MD, PhD, Clinical Instructor of Radiology, New York University School of Medicine; Head of Thoracic Imaging, Department of Radiology, Lenox Hill Hospital
Mina Farhad, MD is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.

Klaus-Dieter Lessnau, MD, FCCP, Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory; Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital
Klaus-Dieter Lessnau, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Artificial Internal Organs, American Thoracic Society, Physicians for Social Responsibility, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Medical Editor

Satinder P Singh, MD, Associate Professor of Radiology, Chief of Cardiopulmonary Radiology, Director of Cardiac CT, Director of Combined Cardiopulmonary and Abdominal Radiology, Department of Radiology, University of Alabama at Birmingham
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Eric J Stern, MD, Professor of Radiology, Adjunct Professor of Medicine, Adjunct Professor of Medical Education and Biomedical Informatics, University of Washington School of Medicine; Director of Thoracic Imaging, Harborview Medical Center; Associate Medical Staff, Seattle Cancer Care Alliance
Eric J Stern, MD is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, European Society of Radiology, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Kavita Garg, MD, Professor, Department of Radiology, University of Colorado Health Sciences Center
Kavita Garg, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.